Haojie Zhang
- Cancer Research top 5%
- MicroRNA in disease regulation 7
- Neurology top 5%
- Molecular Biology top 5%
- Inflammasome and immune disorders 10
- Extracellular vesicles in disease 8
- RNA modifications and cancer 5
-
- Spinal Cord Injury Research 11
- Spine and Intervertebral Disc Pathology 6
- Immunology top 10%
-
- Autophagy in Disease and Therapy 13
-
- HIV/AIDS drug development and treatment 5
- Journals
- Journal of Neuroinflammation (3 papers)Frontiers in Nutrition (3 papers)British Journal of Pharmacology (3 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Haojie Zhang
123 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Cancer Research 459
- Neurology 174
- Molecular Biology 1.4k
- Pathology and Forensic Medicine 367
- Immunology 408
Countries citing papers authored by Haojie Zhang
This map shows the geographic impact of Haojie Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haojie Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haojie Zhang more than expected).
Fields of papers citing papers by Haojie Zhang
This network shows the impact of papers produced by Haojie Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haojie Zhang. The network helps show where Haojie Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Haojie Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 6 | |
| 7 | 2024 | 11 | |
| 8 | 2024 | 27 | |
| 9 | 2024 | 0 | |
| 10 | 2024 | 35 | |
| 11 | 2024 | 7 | |
| 12 | Recent development of multi-target VEGFR-2 inhibitors for the cancer therapybreakdown → | 2023 | 93 |
| 13 | 2023 | 8 | |
| 14 | 2023 | 25 | |
| 15 | 2023 | 3 | |
| 16 | 2023 | 7 | |
| 17 | 2023 | 5 | |
| 18 | 2021 | 72 | |
| 19 | 2021 | 27 | |
| 20 | 2008 | 265 |
About Haojie Zhang
Haojie Zhang is a scholar working on Pathology and Forensic Medicine, Parasitology and Cancer Research, having authored 133 papers that have together received 2.7k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (13 papers), Spinal Cord Injury Research (11 papers), Inflammasome and immune disorders (10 papers), Extracellular vesicles in disease (8 papers), MicroRNA in disease regulation (7 papers), Spine and Intervertebral Disc Pathology (6 papers), RNA modifications and cancer (5 papers) and HIV/AIDS drug development and treatment (5 papers). The work is most often cited by research in Cancer Research (459 citations), Neurology (174 citations) and Molecular Biology (1.4k citations). Haojie Zhang has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Kailiang Zhou, Xinli Hu, Jianping Zhang, Xiangyang Wang, Sheng Lu, Xiuhong Zhang, Qian Gao, Fengyu Zhu, Yang Li and Yao Li. Their work appears in journals such as Journal of Neuroinflammation, Frontiers in Nutrition, British Journal of Pharmacology, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.